US SB2510 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 26 2023 - 25% progression, died in committee
Action: 2023-07-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 26 2023 - 25% progression, died in committee
Action: 2023-07-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Title
RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act
Sponsors
| Sen. Gary Peters [D-MI] | Sen. Sherrod Brown [D-OH] | Sen. Marsha Blackburn [R-TN] | Sen. Ted Budd [R-NC] |
| Sen. Peter Welch [D-VT] | Sen. Joni Ernst [R-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-07-26 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB6802 (Same As) 2023-12-15 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/2510/all-info |
| Text | https://www.congress.gov/118/bills/s2510/BILLS-118s2510is.pdf |
